Amedeo Smart

Free Medical Literature Service


 

Amedeo

Autoimmune Disorders

  Free Subscription

Articles published in
J Autoimmun
    November 2021
  1. AVCI E, Abasiyanik F
    Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?
    J Autoimmun. 2021;125:102745.
    >> Share

  2. FERRI C, Ursini F, Gragnani L, Raimondo V, et al
    Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups.
    J Autoimmun. 2021;125:102744.
    >> Share

    October 2021
  3. TZIOUFAS AG, Bakasis AD, Goules AV, Bitzogli K, et al
    A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases.
    J Autoimmun. 2021;125:102743.
    >> Share

  4. HANSEN N, Krasiuk I, Titsch T
    Neural autoantibodies in delirium.
    J Autoimmun. 2021;125:102740.
    >> Share

  5. GARRIDO I, Lopes S, Simoes MS, Liberal R, et al
    Autoimmune hepatitis after COVID-19 vaccine - more than a coincidence.
    J Autoimmun. 2021;125:102741.
    >> Share

  6. PATRIZIO A, Ferrari SM, Antonelli A, Fallahi P, et al
    A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination.
    J Autoimmun. 2021;125:102738.
    >> Share

    September 2021
  7. GATTO M, Saccon F, Andreoli L, Bartoloni E, et al
    Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort.
    J Autoimmun. 2021;124:102729.
    >> Share

  8. RELA M, Jothimani D, Vij M, Rajakumar A, et al
    Auto-immune hepatitis following COVID vaccination.
    J Autoimmun. 2021;123:102688.
    >> Share

  9. BOGIE JFJ, Vanmierlo T, Vanmol J, Timmermans S, et al
    Liver X receptor beta deficiency attenuates autoimmune-associated neuroinflammation in a T cell-dependent manner.
    J Autoimmun. 2021;124:102723.
    >> Share

    August 2021
  10. LEE AYS, Reed JH, Gordon TP
    Anti-Ro60 and anti-Ro52/TRIM21: Two distinct autoantibodies in systemic autoimmune diseases.
    J Autoimmun. 2021;124:102724.
    >> Share

  11. HIRSIGER JR, Tamborrini G, Harder D, Bantug GR, et al
    Chronic inflammation and extracellular matrix-specific autoimmunity following inadvertent periarticular influenza vaccination.
    J Autoimmun. 2021;124:102714.
    >> Share

  12. HEMED-SHAKED M, Cowman MK, Kim JR, Huang X, et al
    MTADV 5-MER peptide suppresses chronic inflammations as well as autoimmune pathologies and unveils a new potential target-Serum Amyloid A.
    J Autoimmun. 2021;124:102713.
    >> Share

  13. HANSEN RB, Simard JF, Faurschou M, Jacobsen S, et al
    Distinct patterns of comorbidity prior to diagnosis of incident systemic lupus erythematosus in the Danish population.
    J Autoimmun. 2021;123:102692.
    >> Share

  14. LU Q, Long H, Chow S, Hidayat S, et al
    Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus.
    J Autoimmun. 2021;123:102707.
    >> Share

    July 2021
  15. VUILLE-LESSARD E, Montani M, Bosch J, Semmo N, et al
    Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.
    J Autoimmun. 2021;123:102710.
    >> Share

  16. ZHOU S, Li Q, Zhou S, Zhao M, et al
    A novel humanized cutaneous lupus erythematosus mouse model mediated by IL-21-induced age-associated B cells.
    J Autoimmun. 2021;123:102686.
    >> Share

  17. IBANEZ-VEGA J, Vilchez C, Jimenez K, Guevara C, et al
    Cellular and molecular regulation of the programmed death-1/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases.
    J Autoimmun. 2021;123:102702.
    >> Share

  18. BAKASIS AD, Mavragani CP, Boki KA, Tzioufas AG, et al
    COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review.
    J Autoimmun. 2021;123:102687.
    >> Share

  19. GHIELMETTI M, Schaufelberger HD, Mieli-Vergani G, Cerny A, et al
    Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?
    J Autoimmun. 2021;123:102706.
    >> Share

  20. GRAVER JC, Abdulahad W, van der Geest KSM, Heeringa P, et al
    Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica.
    J Autoimmun. 2021;123:102684.
    >> Share

  21. REN HM, Lukacher AE, Rahman ZSM, Olsen NJ, et al
    New developments implicating IL-21 in autoimmune disease.
    J Autoimmun. 2021;122:102689.
    >> Share

  22. MCEACHERN E, Carroll AM, Fribourg M, Schiano TD, et al
    Corrigendum to "Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis" [J. Autoimmun. 119C (2021) 102629].
    J Autoimmun. 2021;121:102665.
    >> Share

  23. MCGONAGLE D, De Marco G, Bridgewood C
    Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
    J Autoimmun. 2021;121:102662.
    >> Share

  24. DOTAN A, Shoenfeld Y
    Perspectives on vaccine induced thrombotic thrombocytopenia.
    J Autoimmun. 2021;121:102663.
    >> Share

    June 2021
  25. LINGEL H, Meltendorf S, Billing U, Thurm C, et al
    Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.
    J Autoimmun. 2021;122:102682.
    >> Share

  26. DIANA T, Ungerer M, Wuster C, Fassbender J, et al
    A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine /collagen content in a long-term Graves' disease mouse model.
    J Autoimmun. 2021;122:102666.
    >> Share

  27. GU Y, Merriman C, Guo Z, Jia X, et al
    Novel autoantibodies to the beta-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes.
    J Autoimmun. 2021;122:102677.
    >> Share

  28. RODRIGUEZ-PEREZ AI, Labandeira CM, Pedrosa MA, Valenzuela R, et al
    Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19.
    J Autoimmun. 2021;122:102683.
    >> Share

  29. KRILIS M, Qi M, Ioannou Y, Zhang JY, et al
    Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk.
    J Autoimmun. 2021;122:102675.
    >> Share

  30. KJELDSEN J, Nielsen J, Ellingsen T, Knudsen T, et al
    Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark.
    J Autoimmun. 2021;120:102632.
    >> Share

    May 2021
  31. NISHIMURA T, Okayasu T, Hosoi H, Kitahara T, et al
    Long-term (16-26 years) follow-up outcome of steroid therapy in refractory autoimmune sensorineural hearing loss.
    J Autoimmun. 2021;121:102664.
    >> Share

  32. TAKESHITA M, Suzuki K, Nakazawa M, Kamata H, et al
    Antigen-driven autoantibody production in lungs of interstitial lung disease with autoimmune disease.
    J Autoimmun. 2021;121:102661.
    >> Share

  33. GRAHAM JJ, Longhi MS, Heneghan MA
    T helper cell immunity in pregnancy and influence on autoimmune disease progression.
    J Autoimmun. 2021;121:102651.
    >> Share

  34. GHESQUIERE T, Ciudad M, Ramon A, Greigert H, et al
    Mucosal-associated invariant T cells in Giant Cell Arteritis.
    J Autoimmun. 2021;121:102652.
    >> Share

  35. KIM JS, Kim IH, Byun JM, Chang JH, et al
    Population-based study on the association between autoimmune disease and lymphoma: National Health Insurance Service-National Sample Cohort 2002-2015 in Korea.
    J Autoimmun. 2021;121:102647.
    >> Share

    April 2021
  36. VALENTI L, Griffini S, Lamorte G, Grovetti E, et al
    Corrigendum to "Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19" [J. Autoimmun. 117C (2020) 102595].
    J Autoimmun. 2021;120:102646.
    >> Share

  37. WILHELM M, Bonam SR, Schall N, Bendorius M, et al
    Implication of a lysosomal antigen in the pathogenesis of lupus erythematosus.
    J Autoimmun. 2021;120:102633.
    >> Share

  38. WANG JY, Zhang W, Roehrl MW, Roehrl VB, et al
    An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19.
    J Autoimmun. 2021;120:102644.
    >> Share

  39. VAN WIGCHEREN GF, Roelofs D, Figdor CG, Florez-Grau G, et al
    Three distinct tolerogenic CD14(+) myeloid cell types to actively manage autoimmune disease: Opportunities and challenges.
    J Autoimmun. 2021;120:102645.
    >> Share

    March 2021
  40. HALPERT G, Watad A, Tsur AM, Dotan A, et al
    Autoimmune dysautonomia in women with silicone breast implants.
    J Autoimmun. 2021;120:102631.
    >> Share

  41. MCEACHERN E, Carroll AM, Fribourg M, Schiano TD, et al
    Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis.
    J Autoimmun. 2021;119:102629.
    >> Share

    February 2021
  42. LONGHI MS, Mieli-Vergani G, Vergani D
    Regulatory T cells in autoimmune hepatitis: Un updated overview.
    J Autoimmun. 2021;119:102619.
    >> Share

  43. PALM AE, Kleinau S
    Marginal zone B cells: From housekeeping function to autoimmunity?
    J Autoimmun. 2021;119:102627.
    >> Share

  44. KHOSRAVI-MAHARLOOEI M, Li H, Hoelzl M, Zhao G, et al
    Role of the thymus in spontaneous development of a multi-organ autoimmune disease in human immune system mice.
    J Autoimmun. 2021;119:102612.
    >> Share

    January 2021
  45. MOLDOVEANU Z, Suzuki H, Reily C, Satake K, et al
    Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.
    J Autoimmun. 2021;118:102593.
    >> Share

  46. PENG B, Temple BR, Yang J, Geng S, et al
    Identification of a primary antigenic target of epitope spreading in endemic pemphigus foliaceus.
    J Autoimmun. 2021;116:102561.
    >> Share

    December 2020
  47. BUITRAGO-MOLINA LE, Pietrek J, Noyan F, Schlue J, et al
    Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis.
    J Autoimmun. 2020;117:102591.
    >> Share

  48. NOVELLI L, Motta F, De Santis M, Ansari AA, et al
    The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.
    J Autoimmun. 2020;117:102592.
    >> Share

    November 2020
  49. SARMIENTO-MONROY JC, Espinosa G, Londono MC, Meira F, et al
    A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center.
    J Autoimmun. 2020;117:102580.
    >> Share

  50. ALBORZIAN DEH SHEIKH A, Gomaa S, Li X, Routledge M, et al
    A Guillain-Barre syndrome-associated SIGLEC10 rare variant impairs its recognition of gangliosides.
    J Autoimmun. 2020 Nov 19:102571. doi: 10.1016/j.jaut.2020.102571.
    >> Share

    September 2020
  51. GORABI AM, Hajighasemi S, Kiaie N, Gheibi Hayat SM, et al
    Corrigendum to "The pivotal role of CD69 in autoimmunity" [J. Autoimmun. 111C (2020) 102453].
    J Autoimmun. 2020 Sep 30:102548. doi: 10.1016/j.jaut.2020.102548.
    >> Share

  52. GOKHALE AS, Gangaplara A, Lopez-Occasio M, Thornton AM, et al
    Corrigendum to "Selective deletion of Eos (Ikzf4) in T-regulatory cells leads to loss of suppressive function and development of systemic autoimmunity" [J. Autoimmun. 105C (2019) 102300].
    J Autoimmun. 2020 Sep 24:102544. doi: 10.1016/j.jaut.2020.102544.
    >> Share

  53. CALABRESE LH, Caporali R, Blank CU, Kirk AD, et al
    Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer.
    J Autoimmun. 2020 Sep 23:102546. doi: 10.1016/j.jaut.2020.102546.
    >> Share

  54. LOMBARDI A, Concepcion E, Hou H, Arib H, et al
    Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes.
    J Autoimmun. 2020 Sep 17:102543. doi: 10.1016/j.jaut.2020.102543.
    >> Share

  55. ZHAO Y, Wei W, Liu ML
    Extracellular vesicles and lupus nephritis - New insights into pathophysiology and clinical implications.
    J Autoimmun. 2020 Sep 4:102540. doi: 10.1016/j.jaut.2020.102540.
    >> Share

    August 2020
  56. GORABI AM, Kiaie N, Aslani S, Jamialahmadi T, et al
    Prospects for the potential of RNA interference in the treatment of autoimmune diseases: Small interfering RNAs in the spotlight.
    J Autoimmun. 2020 Aug 8:102529. doi: 10.1016/j.jaut.2020.102529.
    >> Share

    July 2020
  57. PATSOURAS M, Tsiki E, Karagianni P, Vlachoyiannopoulos PG, et al
    The role of thrombospondin-1 in the pathogenesis of antiphospholipid syndrome.
    J Autoimmun. 2020 Jul 21:102527. doi: 10.1016/j.jaut.2020.102527.
    >> Share

  58. MARZIALE A, Bettacchioli E, Picart G, Nafai S, et al
    Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases.
    J Autoimmun. 2020 Jul 18:102524. doi: 10.1016/j.jaut.2020.102524.
    >> Share

  59. LIU Y, Wang J, Luo S, Zhan Y, et al
    The roles of PPARgamma and its agonists in autoimmune diseases: A comprehensive review.
    J Autoimmun. 2020 Jul 1:102510. doi: 10.1016/j.jaut.2020.102510.
    >> Share

    June 2020
  60. THOME R, Casella G, Lotfi N, Ishikawa LWL, et al
    Primaquine elicits Foxp3(+) regulatory T cells with a superior ability to limit CNS autoimmune inflammation.
    J Autoimmun. 2020 Jun 25:102505. doi: 10.1016/j.jaut.2020.102505.
    >> Share

  61. BING SJ, Silver PB, Jittayasothorn Y, Mattapallil MJ, et al
    Autoimmunity to neuroretina in the concurrent absence of IFN-gamma and IL-17A is mediated by a GM-CSF-driven eosinophilic inflammation.
    J Autoimmun. 2020 Jun 24:102507. doi: 10.1016/j.jaut.2020.102507.
    >> Share

  62. THAM EL, Freeley SJ, Bearder S, Barros FF, et al
    VISTA deficiency protects from immune complex-mediated glomerulonephritis by inhibiting neutrophil activation.
    J Autoimmun. 2020 Jun 22:102501. doi: 10.1016/j.jaut.2020.102501.
    >> Share

  63. HU S, Liu X, Li T, Li Z, et al
    LAG3 (CD223) and autoimmunity: Emerging evidence.
    J Autoimmun. 2020 Jun 20:102504. doi: 10.1016/j.jaut.2020.102504.
    >> Share

  64. DANG J, Xu Z, Xu A, Liu Y, et al
    Human gingiva-derived mesenchymal stem cells are therapeutic in lupus nephritis through targeting of CD39(-)CD73 signaling pathway.
    J Autoimmun. 2020 Jun 18:102491. doi: 10.1016/j.jaut.2020.102491.
    >> Share

  65. EFRAIM Y, Chen FYT, Stashko C, Cheong KN, et al
    Alterations in corneal biomechanics underlie early stages of autoimmune-mediated dry eye disease.
    J Autoimmun. 2020 Jun 18:102500. doi: 10.1016/j.jaut.2020.102500.
    >> Share

  66. RODRIGUEZ Y, Novelli L, Rojas M, De Santis M, et al
    Autoinflammatory and autoimmune conditions at the crossroad of COVID-19.
    J Autoimmun. 2020 Jun 16:102506. doi: 10.1016/j.jaut.2020.102506.
    >> Share

  67. ZHOU X, Kailemia MJ, Sun Y, Shuai Z, et al
    Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis.
    J Autoimmun. 2020 Jun 13:102503. doi: 10.1016/j.jaut.2020.102503.
    >> Share

  68. ZEN M, Fuzzi E, Astorri D, Saccon F, et al
    SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.
    J Autoimmun. 2020 Jun 8:102502. doi: 10.1016/j.jaut.2020.102502.
    >> Share

  69. WONG HY, Schwarz H
    CD137 / CD137 ligand signalling regulates the immune balance: A potential target for novel immunotherapy of autoimmune diseases.
    J Autoimmun. 2020 Jun 4:102499. doi: 10.1016/j.jaut.2020.102499.
    >> Share

  70. WONG ASL, Gruber DR, Richards AL, Sheldon K, et al
    Tolerization of recent thymic emigrants is required to prevent RBC-specific autoimmunity.
    J Autoimmun. 2020 Jun 2:102489. doi: 10.1016/j.jaut.2020.102489.
    >> Share

    May 2020
  71. KOMICI K, Faris P, Negri S, Rosti V, et al
    Systemic lupus erythematosus, endothelial progenitor cells and intracellular Ca(2+) signaling: A novel approach for an old disease.
    J Autoimmun. 2020 May 29:102486. doi: 10.1016/j.jaut.2020.102486.
    >> Share

  72. COLASANTI T, Sabatinelli D, Mancone C, Giorgi A, et al
    Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients.
    J Autoimmun. 2020 May 27:102470. doi: 10.1016/j.jaut.2020.102470.
    >> Share

  73. DE BONT CM, Stokman MEM, Faas P, Thurlings RM, et al
    Autoantibodies to neutrophil extracellular traps represent a potential serological biomarker in rheumatoid arthritis.
    J Autoimmun. 2020 May 22:102484. doi: 10.1016/j.jaut.2020.102484.
    >> Share

  74. YANG Y, Peng F, Wang R, Yang M, et al
    Corrigendum to "The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China" [J. Autoimmun. 109C (2020) 102434].
    J Autoimmun. 2020 May 15:102487. doi: 10.1016/j.jaut.2020.102487.
    >> Share

  75. CARL PL, Fried HM, Cohen PL
    Proteins in assemblages formed by phase separation possess properties that promote their transformation to autoantigens: Implications for autoimmunity.
    J Autoimmun. 2020 May 11:102471. doi: 10.1016/j.jaut.2020.102471.
    >> Share

    April 2020
  76. ZHANG D, Kinloch AJ, Srinath A, Shenkar R, et al
    Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu.
    J Autoimmun. 2020 Apr 30:102469. doi: 10.1016/j.jaut.2020.102469.
    >> Share

  77. LONG D, Chen Y, Wu H, Zhao M, et al
    Corrigendum to "Clinical Significance and Immunobiology of IL-21 in Autoimmunity"[J. Autoimmun. 99C (2019) p1-14].
    J Autoimmun. 2020 Apr 28:102455. doi: 10.1016/j.jaut.2020.102455.
    >> Share

  78. ZHANG X, Olsen N, Zheng SG
    The progress and prospect of regulatory T cells in autoimmune diseases.
    J Autoimmun. 2020 Apr 15:102461. doi: 10.1016/j.jaut.2020.102461.
    >> Share

  79. GORABI AM, Hajighasemi S, Kiaie N, Gheibi Hayat SM, et al
    The pivotal role of CD69 in autoimmunity.
    J Autoimmun. 2020 Apr 11:102453. doi: 10.1016/j.jaut.2020.102453.
    >> Share

  80. LEVITE M, Zelig D, Friedman A, Ilouz N, et al
    Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells.
    J Autoimmun. 2020 Apr 10:102462. doi: 10.1016/j.jaut.2020.102462.
    >> Share

  81. GATTO M, Radu CM, Luisetto R, Ghirardello A, et al
    Immunization with Pentraxin3 prevents transition from subclinical to clinical lupus nephritis in lupus-prone mice: Insights from renal ultrastructural findings.
    J Autoimmun. 2020 Apr 4:102443. doi: 10.1016/j.jaut.2020.102443.
    >> Share

    March 2020
  82. BAE HR, Leung PSC, Hodge DL, Fenimore JM, et al
    Multi-omics: Differential expression of IFN-gamma results in distinctive mechanistic features linking chronic inflammation, gut dysbiosis, and autoimmune diseases.
    J Autoimmun. 2020 Mar 24:102436. doi: 10.1016/j.jaut.2020.102436.
    >> Share

    December 2019
  83. SABOURI S, Benkahla MA, Kiosses WB, Rodriguez-Calvo T, et al
    Human herpesvirus-6 is present at higher levels in the pancreatic tissues of donors with type 1 diabetes.
    J Autoimmun. 2019 Dec 6:102378. doi: 10.1016/j.jaut.2019.102378.
    >> Share

    June 2019
  84. ZENTSOVA I, Parackova Z, Kayserova J, Palova-Jelinkova L, et al
    Monocytes contribute to DNA sensing through the TBK1 signaling pathway in type 1 diabetes patients.
    J Autoimmun. 2019 Jun 27. pii: S0896-8411(19)30191.
    >> Share

  85. TENSPOLDE M, Zimmermann K, Weber LC, Hapke M, et al
    Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.
    J Autoimmun. 2019 Jun 5. pii: S0896-8411(19)30165.
    >> Share

    November 2018
  86. POSTIGO-FERNANDEZ J, Creusot RJ
    A multi-epitope DNA vaccine enables a broad engagement of diabetogenic T cells for tolerance in Type 1 diabetes.
    J Autoimmun. 2018 Nov 17. pii: S0896-8411(18)30523.
    >> Share

    October 2018
  87. ALPER CA, Larsen CE, Trautwein MR, Alford DR, et al
    A stochastic epigenetic Mendelian oligogenic disease model for type 1 diabetes.
    J Autoimmun. 2018 Oct 8. pii: S0896-8411(18)30427.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016